No Data
No Data
No Data
No Data
No Data
Investors Don't See Light At End Of Veracyte, Inc.'s (NASDAQ:VCYT) Tunnel
With a price-to-sales (or "P/S") ratio of 4x Veracyte, Inc. (NASDAQ:VCYT) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States h
Simply Wall StApr 17 07:33 ET
Veracyte Announces That Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Business WireApr 16 08:30 ET
Veracyte Is Maintained at Buy by Goldman Sachs
Veracyte Is Maintained at Buy by Goldman Sachs
Dow JonesApr 15 10:44 ET
Express News | Goldman Sachs Maintains Buy on Veracyte, Lowers Price Target to $28
Moomoo 24/7Apr 15 10:33 ET
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Seeking AlphaApr 14 17:56 ET
Express News | Veracyte Inc : Leerink Partners Cuts Target Price to $34 From $35
Moomoo 24/7Apr 12 08:05 ET
No Data
No Data